Is tamoxifen good enough for the Asian population in ER+ HER2- post-menopausal women with early breast cancer? A nationwide population-based cohort study
Based on real-world data analysis, in ER-positive, HER2-negative post-menopausal women with early breast cancer in Taiwan, the use of tamoxifen compared to AIs is associated with a lower risk of recurrence. Improved adherence to medication can break the cycle of recurrence and improve health outcomes.
Authors
- You-Min Lu (ORCID: https://orcid.org/0000-0001-7739-4050)
- Yi-Chan Lee (ORCID: https://orcid.org/0000-0003-0276-4664)
- Chuan-Hsun Chang
- Chun-Wen Huang
Institutions
- National Taiwan University (TW)
- Cheng Hsin General Hospital (TW)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1371/journal.pone.0313120
- Citations
- 1
- Primary Topic
- Estrogen and related hormone effects
- Type
- article
- Field-Weighted Citation Impact
- 0.55
Funders
- Cheng Hsin General Hospital Foundation